Shuchi Nahar's Weekend Blog!

  Your ultimate guide to understand the basics and details about the Indian Pharma Sector A Brief Understanding On Pharma Sector From Its Key Terms To Its Filing And Procedures. The following article is on the Indian Pharmaceutical Industry, the article is written to familiarize ourselves with the terminology or the jargon’s of the pharmaceutical industry. It will briefly touch upon terms like API, Intermediates, CDMO’s/ CRAM’s, PARA Filings,  Innovator drug, Generic drugs, life cycle development etc. The Indian pharmaceuticals market has characteristics that make it unique. First, branded generics dominate, making up for 70 to 80% of the retail market.  India also has the feather of being the  largest exporter of generic drugs  in the world.  Second, local players have enjoyed a dominant position driven by the formulation development capabilities and early investments.  Third, price levels are low, driven by intense competition. While India ranks tenth globally in terms of value, it

Neuland Labs Ltd Q3FY21 Result Update Twitter Handle: @shuchi_nahar   Link to Company Overview of Neuland Labs in detail: https://myweekendspot.blogspot.com/2020/09/neuland-labs-company-snapshot.html The company has announced consecutive another strong quarter of top-line and bottom-line performance. The revenue at Rs.245.6 crores was a 20% improvement over the corresponding quarter of the last fiscal while the margins have shown an upward trajectory and closed at 19.0%. This was driven by growth across the GDS and CMS verticals. The company remains confident of its long-term growth aspirations as well as its margin resilience.  • Total income increased by 20.0% in Q3FY21 on account of secular growth in GDS and CMS. • Prime segment continues growth led by Levetiracetam and Mirtazapine. • Speciality business had a stable quarter led by Deferasirox and Dorzolamide. • CMS business witnessed growth in scale-up projects and higher projects coming up for validation. • Two APIs ship

  Strides Pharma Sciences Ltd.(STAR) - Company Overview Twitter Handle:  shuchi_nahar       1)  Company Profile Strides is a global pharmaceutical company headquartered in Bangalore. The Company has two business verticals, Regulated Markets and Emerging Markets. The Company has a global manufacturing footprint with 7 manufacturing facilities spread across three continents including 5 facilities for Regulated Markets and 2 facilities for Emerging Markets. The Company has a strong R&D infrastructure in India with global filing capabilities and a strong commercial footprint across 100 countries. The core generic pharma business of Strides is led by IP-driven product licensing and marketing and distribution partnerships across the globe. Strides have created an exhaustive pipeline of generics across varied formats and domains including oral dosage forms and topicals. The company is among the leading players worldwide in soft gel capsules. Their domain strategy of developing a compr